argenx SE Beat Consensus Estimates
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Go beyond the consensus and become a better stock picker with Earnings Whisper numbers, investor sentiment, and proprietary research and tools to help you capture the Post-Earnings Announcement Drift (PEAD) and outperform the overall stock market. Plus, get the most accurate earnings dates, earnings news, and insights into how stocks react before and after earnings.
The most anticipated earnings releases for the week beginning October 22, 2026 are
CAJPY
Canon
BE
Bloom Energy
MSFT
Microsoft
GOOGL
Alphabet
LMT
Lockheed Martin
Earnings Expectation Life Cycle
A stock does not go from cheap to expensive at random. It moves through four recurring phases, set by two things: which way earnings estimates are heading, and whether investors have noticed yet. Get the pair right and a falling stock that keeps falling looks entirely different from one that is about to turn.
Bearish sentiment, falling estimates. Looks inexpensive, keeps underperforming. Declined in 59% of quarters.
Estimates turn up while sentiment is still bearish. The inflection, and the best risk-reward in the cycle.
Bullish sentiment, rising estimates. The established trend, and historically the strongest of the four.
Estimates roll over while sentiment stays bullish. Bernstein called it the Torpedo, and the decline is abrupt.
Worked through with Amedisys, Callon Petroleum, NVIDIA, and SolarEdge.
Read the research
CAJPY
Canon
is confirmed to report Tuesday, October 27, before the open.
Canon heads into its September-quarter report with an unusual split between price and mood. The shares have climbed 7.7% since the company last reported, beating the S&P 500 by more than five percentage points, and now sit within a whisker of their post-earnings high. Yet sentiment among retail investors has soured, sliding to 28.3% bearish from 14.0% bearish ahead of the prior report. A stock that keeps rising while the crowd grows more skeptical raises the question this release must settle: is the rally resting on durable earnings power, or has it run ahead of the fundamentals?
The numbers set an undemanding hurdle on one measure and a tougher one on another. In the year-ago September quarter, Canon earned $0.48 per share on revenue of $7.49 billion. Last quarter it earned $0.89 per share on $7.41 billion in sales, nearly double the year-ago figure on slightly lower revenue. That gap is the heart of the setup. If Canon can deliver anything close to last quarter's profitability on a similar revenue base, the year-over-year comparison will look dramatic. But the more meaningful test is whether the margin structure behind that $0.89 holds, because the top line itself has not been growing. Revenue roughly flat against last year means earnings gains have to come from mix, pricing, cost discipline or currency rather than volume. No clear published consensus figure is available to anchor expectations, and management has not offered fresh quantitative guidance since the last report, so the market will judge the quarter largely against Canon's own recent run rate.
The recent, most closely watched, earnings results.
AMKBY 22.2% since the report 21.5% above its post-earnings high
For more than 25 years, investors and financial professionals have used Earnings Whispers to look beyond consensus estimates and better understand the expectations driving stock prices around earnings.
Learn more about Earnings Whispers